Financhill
Back

Glaukos Quote, Financials, Valuation and Earnings

Glaukos Price Quote

$127.87
+0.01 (+-2.67%)
(Updated: November 6, 2024 at 5:12 AM ET)

Glaukos Key Stats

Sell
44
Glaukos (GKOS) is a Sell

Day range:
$124.60 - $131.09
52-week range:
$59.22 - $139.51
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.11
P/B ratio:
10.55%

Volume:
1.6M
Avg. volume:
485.5K
1-year change:
99.13%
Market cap:
$7B
Revenue:
$314.7M
EPS:
$-2.96

How Much Does Glaukos Make?

  • How Much Are Glaukos's Sales Annually?
    GKOS Revenues are $314.7M
  • How Much Profit Does Glaukos's Make A Year?
    GKOS net income is -$134.7M

Is Glaukos Growing As A Company?

  • What Is Glaukos's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Glaukos's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Glaukos Stock Price Performance

  • Did Glaukos Stock Go Up Last Month?
    Glaukos share price went down by -2.38% last month
  • Did GKOS's Share Price Rise Over The Last Year?
    GKOS share price rose by 99.13% over the past 1 year

What Is Glaukos 52-Week High & Low?

  • What Is Glaukos’s 52-Week High Share Price?
    Glaukos has traded as high as $139.51 over the past 52 weeks
  • What Is Glaukos’s 52-Week Low Share Price?
    Glaukos has traded as low as $59.22 over the past 52 weeks

Glaukos Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Glaukos?

  • How Much Debt Does Glaukos Have?
    Total long term debt quarterly is $56.8M
  • How Much Cash Does Glaukos Have?
    Cash and short term investments quarterly total is $262.5M
  • What Is Glaukos’s Book Value Per Share?
    Book value per share is 12.13

Is Glaukos Cash Flow Positive?

  • What Is GKOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$72.5M
  • What Is Glaukos’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $38.7M
  • What Is Glaukos’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $23.1M

Glaukos Return On Invested Capital

  • Is Management Doing A Good Job?
    GKOS return on invested capital is -20.29%
  • What Is Glaukos Return On Assets?
    ROA measures how assets are converting to revenues and is -16.02%
  • What Is GKOS Return On Equity?
    ROE is a measure of profitability and is -27.46%

Glaukos Earnings Date & Stock Price

  • What Is Glaukos's Stock Price Today?
    A single share of GKOS can be purchased today for 127.86
  • What Is Glaukos’s Stock Symbol?
    Glaukos trades on the nyse under the ticker symbol: GKOS
  • When Is Glaukos’s Next Earnings Date?
    The next quarterly earnings date for Glaukos is scheduled on February 21, 2025
  • When Is GKOS's next ex-dividend date?
    Glaukos's next ex-dividend date is November 6, 2024
  • How To Buy Glaukos Stock?
    You can buy Glaukos shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Glaukos Competitors

  • Who Are Glaukos's Competitors?
    Below is a list of companies who compete with Glaukos or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • iRhythm Technologies Inc (IRTC)
    • Xtant Medical Holdings Inc (XTNT)

Glaukos Dividend Yield

  • What Is GKOS Dividend Yield?
    Glaukos’s dividend yield currently is 0%
  • What Is Glaukos’s Payout Ratio?
    Glaukos’s payout ratio is 0%
  • When Did Glaukos Last Pay A Dividend?
    The latest dividend pay date is November 6, 2024
  • What Is Glaukos’s Dividend Per Share?
    Glaukos pays a dividend of $0.00 per share

Glaukos Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 41.43%
Revenue: 23.86% 5.69%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 139.82
Upside from Last Price: 9.35%

Major Shareholders

  • How many GKOS shares are owned by institutional investors?
    94.2M GKOS shares are owned by institutional investors
  • How many GKOS shares are owned by insiders?
    699.6K GKOS shares are owned by insiders